FDA Inspection 548970 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Nov 6, 2008 in Basel Town. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 6, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basel Town (Switzerland)
Additional details
Sponsor, Contract Research Organization